Rezivertinib
Product Specifications
CAS Number
1835667-12-3
Synonyms
BPI-7711
SKU
C03274-5mg
Target
EGFR
Applications
Protein Tyrosine Kinase
Additionnal Information
Rezivertinib (BPI-7711) is a potent third-generation inhibitor of EGFR tyrosine kinase, targeting both EGFR-sensitizing mutations and the EGFR T790M mutation. Additionally, it has excellent CNS penetration and has antitumor activity.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
